Monday, 19 November 2018

Microbiology Testing Market 2018 - Opportunity, Driving Trends and deep study 2023

Market Scenario
The rising costs of surgeries and overall healthcare has induced the need for hospitals to lean towards technology to reduce the burden. Microbiology Testing (RCM) is a system in the healthcare cycle which relies on electronic health records (EHRs) and automation to expedite outpatient billing and reduce wait times. The global Microbiology Testing market is touted to exhibit a healthy 12.2% CAGR during the assessment period (2017-2027), as per a new market report by Market Research Future (MRFR).
The growing numbers of hospitals and clinics, rising adoption rate of RCM software, recovery audits, and preference for integrated healthcare systems are factors expected to drive market demand during the forecast period.
Key Players for Global Microbiology testing Market:                                 
Alere (US)
BD (US)
Beckman Coulter, Inc. (US)
Cepheid (US)
Thermo Fisher Scientific Inc. (US)
  1. Hoffmann-La Roche Ltd (Switzerland)
Biomérieux SA (France)
Segments:                                                                                                                                        
Global Microbiology testing Market has been segmented on the basis of type which comprise Instruments, Chemicals & Reagents, Consumables & Accessories, and others. On the basis of application, it is segmented into, Gastrointestinal Infections, Respiratory Infections, Urinary tract Infections, Sexually Transmitted Infections, Others. On the basis of end user, it is segmented into, Hospital based laboratory, Independent laboratory, and Academics & Research Institutes.
Regional Analysis of Global Microbiology testing Market:                   
Considering the global scenario of the market, North America was holding largest market share of 37.9% in global Microbiology testing market in 2016. Asia-Pacific is second largest and fastest growing market in global Microbiology testing market. APAC is expected to grow at a CAGR of 12.1% during 2017-2023. Europe was second largest microbiology testing market and is expected to grow at a significantly during the forecast period. On the other hand. Middle East and Africa (ME&A) microbiology testing market was growing lower than global average and expected to grow at steady pace. 
Browse Complete 129 Pages Premium Research Report Enabled with 129 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/microbiology-testing-market-697

Detailed Table of Contents:
TABLE OF CONTENTS
1  Report Prologue
2  Introduction
2.1 Scope Of Study 17
2.2 Research Objective 17
2.3 Assumptions & Limitations 17
2.3.1 Assumptions 17
2.3.2 Limitations 17
2.4 Market Structure 18
3  Research Methodology
3.1 Primary Research 21
3.2 Secondary Research 21
3.3 Market Size Estimation 21
3.3.1 Market Share Analysis 22
3.4 Market Pricing Approach 23
4 Market Dynamics
4.1 Introduction 
4.2 Drivers 
4.2.1 Technological Advancements 
4.2.2 Rising Cases Of Infectious Diseases 
4.2.3 Surveillance Programs For Disease Control 
4.2.4 Rising Stringency Of Standards 
4.2.5 Weakness Of Traditional Laboratory Techniques 
...Continued

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

MHealth Applications Market 2018 Market Challenge, Driver, Trends & Forecast to 2023

Market Scenario
mHealth is one of the most innovative and disruptive trends in healthcare sector that is growing at prodigious rate from last few years. mHealth is changing the way of traditional medical practices and creating path for the future of healthcare. mHealth assists to check and maintain the health related activity by using technology such as Bluetooth, mobile network (GSM/GPRS/3G/4G), and Wi-Fi. The data collected by mHealth devices such as mobile phones, tablets, laptops and tablet PCs assist to medical professional, consumers, and other users.
Considering the global scenario of the mHealth applications market, the total market for mHealth application was US$ XX billion in 2016 and expected to reach US$ 100.2 billion by 2023. While considering the segments, monitoring application is holding largest market share that is about 53.8% in 2016.
Key Players for Global mHealth Applications Market: 
Some of the key players in this market are: Allscripts (US), Agamatrix, Inc. (US), Apple Inc. (US), Honeywell International Inc. (US), Medtronic MiniMed, Inc. (US), Vivify Health (US) and iHealth Labs Inc. (US).
Segments:
Global MHealth applications Market has been segmented on the basis of type which comprise Monitoring Applications, Diagnosis & Treatment, Education & Awareness, Healthcare Management, Wellness & Prevention, and others.

Regional Analysis of Global mHealth applications Market:
Considering the global scenario of the market, Europe was holding largest market share of 31.7% in global mHealth applications market in 2016. Asia-Pacific is second largest and fastest growing market in global mHealth applications market. APAC is expected to grow at a CAGR of 33.7% during 2017-2023. North America is one of pioneer in mhealth and is slightly behind the APAC. North America is expected to reach USD 28762.1 million by 2023. On the other hand. Middle East and Africa (ME&A) mHealth was valued USD 1334.9 in 2016 and is expected to grow at steady pace during the forecast period.   
Browse Complete 122 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/mhealth-applications-market-3195
Detailed Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Scope Of Study 
2.2 Research Objective 
2.3 Assumptions & Limitations 
2.3.1 Assumptions 
2.3.2 Limitations 
3 Research Methodology
3.1 Research Process 
3.2 Primary Research  
3.3 Secondary Research  
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Innovation And Rapidly Changing Technology
4.2.2 Adoption And Involvement Of Patient
4.2.3 Cost Effectiveness And Convenience
4.2.4 Increasing Prevalence Of Lifestyle Diseases
...Continued

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Middle East and Africa Diabetes Market Volume Forecast and Value Chain Analysis 2018


Market Scenario:

The report for Middle East and Africa Diabetes Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Middle East and Africa Diabetes Market is growing rapidly. Middle East and Africa Diabetes Market is expected to grow at a CAGR of 5.1% and expected to reach US$ 16.4 billion by 2023 from US$ 11.6 billion in 2016.


On an average one in ten adult is suffering from diabetes in Middle East and Africa region. Most of the case are of Type 2 diabetes and it is growing rapidly. According to International Diabetes Federation Atlas, about 19.3% of population between 20-79 age group is diabetic in UAE and the number is almost same in Saudi Arabia, Qatar, Kuwait and Bahrain. These five nations has the highest rate of diabetes per capita which is among the top 15 countries in the world. Increasing urbanization, changing lifestyle and unhealthy eating habits are driving the growth for the market. Rising middle class group, increasing per capita income, spending on healthcare and advanced healthcare infrastructure facilities are driving the growth for the market in this region.
Segments:                                                                                                                                        
Middle East and Africa Diabetes Market has been segmented on the basis of type which comprises Type 1, Type 2, and Gestational diabetes. On the basis of test, market is segmented into Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others. On the basis of devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others. On the basis of treatment market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and others.
Regional Analysis
Considering the scenario of the Middle East and African diabetes market, Saudi Arabia is believed to be the largest market for diabetes. Moreover the UAE also growing and second largest market for Middle East and Africa Diabetes. On the other hand, Egypt market is expected to grow at significant rate in the Middle East and Africa diabetes during the forecasted period. Rest of Middle East and Africa is likely to have a limited but moderate growth in the market.
Key Players
Some of the key players in this market are: Abbott (US), Bayer AG (Germany), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Roche Diabetes Care, Inc. (US), sanofi-aventis U.S. LLC (US), Ypsomed (Switzerland)

List of Tables and Figures:
List Of Tables
Table 1 Middle East and Africa Diabetes Market By Type
Table 2 Middle East and Africa Diabetes Market By Test
Table 3 Middle East and Africa Diabetes Market By Devices
Table 4 Middle East and Africa Diabetes Market By Treatment
Table 5 Middle East and Africa Diabetes Market By Region
List Of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Middle East and Africa Diabetes Market By Type
Figure 4 Middle East and Africa Diabetes Market By Test
Figure 5 Middle East and Africa Diabetes Market By Devices
Figure 5 Middle East and Africa Diabetes Market By Treatment
Figure 7 Middle East and Africa Diabetes Market By Region
Figure 8 Middle East and Africa Diabetes Market By Region: Company Share Analysis, 2015 (%)

...Continued



         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Current and forthcoming Liquid Biopsy Market size in terms of volume and value 2018


A liquid biopsy is a largely non-invasive, sampling and analysis of liquid state biological tissue for diagnostic and monitoring diseases such as cancer. Liquid biopsy is the direct clinical application of two advances in medical science namely human genome sequencing and rising sensitivity of detecting techniques and assays.
The global Liquid Biopsy market is currently valued at $ 3950 million and will reach $ 17,372.28 million growing at a CAGR of 28%. The growth factors responsible for this explosive growth are liquid biopsy is a comparatively painless and non-invasive technique which provides early real time high precision detection of diseases which could be used for monitoring and designing effective treatment strategies based on the real time molecular assessment for the progression of the disease. Other factors driving the liquid biopsy market are lifestyle changes and environmental factors such as rising investment in research and development and collaborations between companies and public organizations, rise in population particularly geriatric population, rising expenditure on health etc. The technique also has other advantages over traditional tissue biopsy such as potential applications to cardiovascular diseases, autoimmune diseases etc.
The restraints include the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. Also not all cancer patients benefit from early detection as some cancers such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.
Key Players for Global Liquid Biopsy market:
Guardant Health, Inc., Trovagene, Inc., RainDance Technologies, Inc., Agena Bioscience Inc. Inc., Admera Health, Biocept, Inc., Circulogene Theranostics,  Inivata Ltd.,  SAGA Diagnostics AB,  Exosome Diagnostics and others.

Segments:

Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centers and others.
Regional Analysis of Global Liquid Biopsy market:
Globally North America is the largest market for Global Liquid Biopsy market. Europe is the second-largest market for Global Liquid Biopsy market. However the developing regions market particularly Asia Pacific will be the fastest growing and will be the key to the future. North America accounted for the largest market share of 37.95% in 2016 accounting for a market value of 1,499.10 million in  2016. Asia pacific is the fastest growing market which is growing at a CAGR of 28.8%.
The report for Global Liquid Biopsy market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse Complete 171  Pages Premium Research Report Enabled with 248 Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710
TABLE OF CONTENTS
1  Report Prologue
2  Introduction
2.1 Definition 
2.2 Scope Of The Study 
2.2.1 Research Objective 
2.2.2 Assumptions 
2.2.3 Limitations 
2.3 Market Structure 
2.4. Market Segmentation 
3 Research Methodology
3.1 Research Process 
3.2 Primary Research 
3.3 Secondary Research 
5 Market Dynamics
4.1 Drivers 
4.2 Restraints 
4.3 Opportunities 
4.4 Mega Trends 
4.5 Macroeconomic Indicators 
5 Market Factor analysis
5.1 Porter’s Five Force Analysis 
5.1.1 Bargaining Power Of Buyer 
5.1.2 Bargaining Power Of Supplier 
5.1.3 Threat From Substitute 
5.1.4 Threat From A New Entrant 
5.1.5 Intensity Of Competitive Rivalry 
...Continued

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Bioinformatics Market Top Trends, Regulations and Competitive Landscape Outlook To 2023

Market scenario:
Bioinformatics is the use of information technology in the field of biotechnology for the purpose of data storage, data warehousing and analyzing the DNA sequences. In bioinformatics technology knowledge about various  branches is required which includes  biology, mathematics, computer science, laws of physics & chemistry along with it  most importantly sound knowledge about  information technology is required to analyze biotechnological data.
Globally the market for bioinformatics is growing steadily and has a bright future, this market expected to grow at the rate of about 19.8% till 2022 and this has started since 2016.
Key Players for Bioinformatics Market:                                                        
Some of the key players in this market are: Agilent Technologies, Illumina, Inc., QIAGEN N. V, and Thermo Fisher Scientific Inc., Dassault Systèmes, QIAGEN and others.   
Segments:                                                                                                                                        
Bioinformatics market has been segmented on the basis of application which comprises of genomics, chemoinformatics, drug design, transcriptomics, molecular phylogenetics, proteomics, metabolomics, DNA sequences and others. On the basis of services and technology the market is segmented into data warehousing, sequence analysis, sequence manipulation and others. On the basis of sector the market is divided into medical bioinformatics, animal bioinformatics, agriculture bioinformatics and others.

Regional Analysis of Bioinformatics Market:                                                         
Globally Americas is the largest market for Bioinformatics. Where in countries like US and Canada play an important role in the growth of the market. Europe is expected to be the second-largest market which is expected to reach US$ XX million by the end of the forecasted period. Furthermore Asia pacific market is expected to be the fastest growing market for Bioinformatics.

Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures @  https://www.marketresearchfuture.com/reports/bioinformatics-market-2265
Detailed Table of Contents:
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5 Global Bioinformatics Market, By Application
5.1 Genomics
5.2 Chemoinformatics
5.3 Drug Design
5.4 Transcriptomics
5.5 Molecular Phylogenetics
5.6 Proteomics
5.7 Metabolomics
5.8 Dna Sequences
5.9 Others
...Continued
         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com